Prediction of patients with multiple myeloma eligible for second- or third-line treatment in France
Crossref DOI link: https://doi.org/10.1007/s00277-016-2688-9
Published Online: 2016-05-10
Published Print: 2016-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Rondeau, Virginie
Cornet, Edouard
Moreau, Philippe
Troussard, Xavier
Text and Data Mining valid from 2016-05-10